{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:12:21Z","timestamp":1760170341742,"version":"3.44.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jneuroim.2006.09.011","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T14:16:09Z","timestamp":1163686569000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission"],"prefix":"10.1016","volume":"182","author":[{"given":"A.","family":"Lucas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Cobelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kavelaars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Heijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Holtmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Haag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Langhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Dobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schedlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Elsenbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2006.09.011_bib1","doi-asserted-by":"crossref","unstructured":"Bercik, P., Verdu, E.F., Collins, S.M., 2005. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol. Clin. North Am. 34:235-vii.","DOI":"10.1016\/j.gtc.2005.02.007"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib3","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1572-0241.2003.07717.x","article-title":"Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study","volume":"98","author":"Bitton","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00001574-200307000-00003","article-title":"Inflammatory bowel disease and irritable bowel syndrome: separate or unified?","volume":"19","author":"Bradesi","year":"2003","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib5","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","article-title":"Activation of the mucosal immune system in irritable bowel syndrome","volume":"122","author":"Chadwick","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib6","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1111\/j.1572-0241.2005.00246.x","article-title":"Dysregulation of peripheral cytokine production in irritable bowel syndrome","volume":"100","author":"Collins","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2005.11.033","article-title":"Hypothalamic\u2013pituitary\u2013gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?","volume":"130","author":"Dinan","year":"2006","journal-title":"Gastroenterology"},{"year":"2000","series-title":"Rome II. The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology And Treatment: A Multinational Consensus","author":"Drossman","key":"10.1016\/j.jneuroim.2006.09.011_bib9"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib10","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","article-title":"Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS","volume":"125","author":"Dunlop","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2249.2005.02722.x","article-title":"Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10","volume":"140","author":"Ebert","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.01.001","article-title":"Tissue specific effects of the beta 2-adrenergic agonist salbutamol on LPS-induced IFN-gamma, IL-10 and TGF-beta responses in vivo","volume":"150","author":"Eijkelkamp","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1572-0241.2001.03526.x","article-title":"Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses","volume":"96","author":"Elsenbruch","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib14","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/j.1572-0241.2005.50071.x","article-title":"Heightened responses to stressors in patients with inflammatory bowel disease","volume":"100","author":"Farhadi","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiocchi","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00844770","article-title":"The relation between daily stress and Crohn's disease","volume":"14","author":"Garrett","year":"1991","journal-title":"J. Behav. Med."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.52.1.91","article-title":"Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?","volume":"52","author":"Gonsalkorale","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0005-7967(94)90114-7","article-title":"Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease","volume":"32","author":"Greene","year":"1994","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/gut.52.4.523","article-title":"Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome","volume":"52","author":"Gwee","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/gut.44.3.400","article-title":"The role of psychological and biological factors in postinfective gut dysfunction","volume":"44","author":"Gwee","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2004-812835","article-title":"Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis","volume":"42","author":"H\u00e4user","year":"2004","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-5728(02)00322-3","article-title":"Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls","volume":"132","author":"Heesen","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02087563","article-title":"Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori","volume":"39","author":"Holtmann","year":"1994","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/40.8.868","article-title":"Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure","volume":"40","author":"Jacobs","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-5728(97)00076-3","article-title":"Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes","volume":"77","author":"Kavelaars","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"K\u00fchn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib27","first-page":"1219","article-title":"Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study","volume":"89","author":"Levenstein","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib28","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1572-0241.2000.02012.x","article-title":"Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission","volume":"95","author":"Levenstein","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1096\/fasebj.13.6.715","article-title":"Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis","volume":"13","author":"Lombardi","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.MIB.0000161919.42878.a0","article-title":"Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis, and future directions","volume":"11","author":"Maunder","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib31","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/gut.2005.064261","article-title":"Psychological stress in IBD: new insights into pathogenic and therapeutic implications","volume":"54","author":"Mawdsley","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib32","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1053\/gast.2002.33584","article-title":"Evolving pathophysiologic models of functional gastrointestinal disorders","volume":"122","author":"Mayer","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib33","doi-asserted-by":"crossref","first-page":"G519","DOI":"10.1152\/ajpgi.2001.280.4.G519","article-title":"Stress and irritable bowel syndrome","volume":"280","author":"Mayer","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.PSY.0000106907.24881.F2","article-title":"Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study","volume":"66","author":"Mittermaier","year":"2004","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000050681","article-title":"Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity","volume":"19","author":"Monnikes","year":"2001","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","article-title":"Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles","volume":"128","author":"O'Mahony","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S1471-4906(03)00173-X","article-title":"How stress influences the immune response","volume":"24","author":"Padgett","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib38","first-page":"163","article-title":"Lessons from genetic models of inflammatory bowel disease","volume":"60","author":"Podolsky","year":"1997","journal-title":"Acta Gastro-Enterol. Belg."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1443-9573.2005.00202.x","article-title":"Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?","volume":"6","author":"Quigley","year":"2005","journal-title":"Chin. J. Dig. Dis."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002689900401","article-title":"Cytokines in inflammatory bowel disease","volume":"22","author":"Rogler","year":"1998","journal-title":"World J. Surg."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2362.1999.00460.x","article-title":"Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease","volume":"29","author":"Rogler","year":"1999","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2002.31072","article-title":"A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease","volume":"122","author":"Sandborn","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/0016-5085(95)90692-4","article-title":"Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease","volume":"108","author":"Schreiber","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib45","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/01.MIB.0000191610.97842.51","article-title":"Regulatory role of the pituitary-adrenal axis in experimental colitis: effect of adrenalectomy on the clinical course and the TH1\/TH2 immune profile","volume":"11","author":"Shibolet","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1542-3565(04)00159-4","article-title":"Infection, immune function, and functional gut disorders","volume":"2","author":"Spiller","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(02)00047-4","article-title":"Uncoupling of the sympathetic nervous0020system and the hypothalamic\u2013pituitary\u2013adrenal axis in inflammatory bowel disease?","volume":"126","author":"Straub","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib48","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1034\/j.1399-0039.1999.540408.x","article-title":"Interleukin-10 (IL-10) genotypes in inflammatory bowel disease","volume":"54","author":"Tagore","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2006.09.011_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-111-8-671","article-title":"A patient questionnaire to identify bowel disease","volume":"111","author":"Talley","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI118469","article-title":"Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia","volume":"97","author":"van der Poll","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib51","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1111\/j.1572-0241.2005.00257.x","article-title":"Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome","volume":"100","author":"van der Veek","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2006.09.011_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/gast.1997.v113.pm9247454","article-title":"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group","volume":"113","author":"van Deventer","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806003791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806003791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:04:41Z","timestamp":1759046681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572806003791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0165572806003791"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.09.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}